Entera Bio (ENTX) Stock Chart & Stock Price History $1.95 +0.04 (+2.09%) As of 07/3/2025 03:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Entera Bio Stock Price Performance The Entera Bio (ENTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 18.90%, with a year-to-date return of -8.02%. In the past month, the stock has decreased 4.88%, reflecting recent market activity. As of the latest close, Entera Bio traded at $1.95 with a market cap of $88.63 million and volume of 18,161 shares. Five years ago, the stock traded at $1.71, representing a 14.04% increase over that period. At the time, it had a market cap of $21.03 million and a volume of 57,000 shares. Receive ENTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.63%1 Month Performance-4.88%3 Month Performance+21.88%Year-To-Date Performance-8.02%1 Year Performance+18.90%5 Year Performance+14.04% ENTX Stock Chart for Friday, July, 4, 2025 ENTX Chart by TradingView Entera Bio Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$1.91$1.95+2.09%$1.96$1.8818,161 shs$88.63 million07/02/2025$1.86$1.91+2.69%$1.94$1.8713,911 shs$86.81 million07/01/2025$1.90$1.86-2.11%$1.96$1.8546,461 shs$84.54 million06/30/2025$1.90$1.90$2.02$1.8411,842 shs$86.36 million06/27/2025$2.00$1.90-4.76%$2.00$1.9115,697 shs$86.36 million06/26/2025$1.97$2.00+1.27%$2.04$1.9614,289 shs$90.67 million06/25/2025$1.96$1.97+0.51%$2.02$1.9117,923 shs$89.54 million06/24/2025$1.97$1.96-0.25%$2.01$1.9213,875 shs$89.08 million06/23/2025$1.98$1.97-0.76%$2.06$1.8696,000 shs$89.31 million06/20/2025$1.99$1.98-0.50%$2.06$1.989,151 shs$89.99 million Get the Latest News and Ratings for ENTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$1.99$1.99$2.09$1.995,076 shs$90.45 million06/18/2025$2.06$1.99-3.21%$2.09$1.995,076 shs$90.45 million06/17/2025$2.00$2.06+2.80%$2.18$1.90117,325 shs$93.45 million06/16/2025$1.86$2.00+7.53%$2.05$1.8446,747 shs$90.90 million06/13/2025$2.09$1.86-11.00%$2.07$1.8452,053 shs$84.54 million06/12/2025$2.10$2.09-0.48%$2.09$2.0111,537 shs$95.00 million06/11/2025$2.13$2.10-1.41%$2.28$2.0446,685 shs$95.45 million06/10/2025$2.12$2.13+0.47%$2.25$2.0840,106 shs$96.81 million06/09/2025$2.07$2.12+2.42%$2.17$1.9029,312 shs$96.36 million06/06/2025$2.01$2.07+2.99%$2.13$1.8734,324 shs$94.09 million06/05/2025$2.05$2.01-1.95%$2.07$1.9619,897 shs$91.36 million06/04/2025$2.08$2.05-1.20%$2.15$1.9731,882 shs$93.18 million06/03/2025$1.94$2.08+6.96%$2.08$1.8788,925 shs$94.31 million Related Companies Humacyte Stock Chart Rezolute Stock Chart Upexi Stock Chart Terns Pharmaceuticals Stock Chart Arcturus Therapeutics Stock Chart Compass Therapeutics Stock Chart Astria Therapeutics Stock Chart SNDL Stock Chart Gossamer Bio Stock Chart MBX Biosciences Stock Chart Receive ENTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENTX) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENTX Stock Alerts